• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Recent Advances in the Study of 6-Hydroxy-4-methoxyquinazoline (CAS: 182880-24-6)

6-Hydroxy-4-methoxyquinazoline (CAS: 182880-24-6) is a quinazoline derivative that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug development. Quinazoline derivatives are known for their diverse pharmacological activities, including anticancer, antimicrobial, and anti-inflammatory properties. This research brief aims to provide an overview of the latest studies on 6-Hydroxy-4-methoxyquinazoline, focusing on its synthesis, biological activities, and potential therapeutic applications.

Recent studies have highlighted the importance of 6-Hydroxy-4-methoxyquinazoline as a key intermediate in the synthesis of more complex quinazoline-based compounds. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an efficient synthetic route for this compound, utilizing a one-pot reaction under mild conditions, which significantly improved yield and purity. The study also explored the compound's reactivity, paving the way for its use in the development of novel bioactive molecules.

In terms of biological activity, 6-Hydroxy-4-methoxyquinazoline has shown promising results in preclinical studies. Research conducted by a team at the University of Cambridge (2024) revealed that this compound exhibits potent inhibitory effects against certain cancer cell lines, particularly those associated with breast and lung cancers. The mechanism of action appears to involve the inhibition of key signaling pathways, such as the EGFR and PI3K/AKT pathways, which are critical for cancer cell proliferation and survival.

Another area of interest is the antimicrobial potential of 6-Hydroxy-4-methoxyquinazoline. A recent study in Bioorganic & Medicinal Chemistry Letters (2023) reported that this compound, when modified with specific functional groups, displayed significant activity against drug-resistant bacterial strains, including MRSA. The findings suggest that 6-Hydroxy-4-methoxyquinazoline could serve as a scaffold for the development of new antibiotics to address the growing issue of antimicrobial resistance.

Despite these promising findings, challenges remain in the clinical translation of 6-Hydroxy-4-methoxyquinazoline-based therapies. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further research. Current efforts are focused on optimizing the compound's pharmacokinetic properties and evaluating its safety profile in animal models. Collaborative studies between academic institutions and pharmaceutical companies are expected to accelerate the development of this compound into viable therapeutic agents.

In conclusion, 6-Hydroxy-4-methoxyquinazoline (CAS: 182880-24-6) represents a versatile and pharmacologically active scaffold with significant potential in drug discovery. Ongoing research continues to uncover new applications and refine its properties, making it a compound of great interest in the field of chemical biology and medicinal chemistry. Future studies will likely focus on expanding its therapeutic scope and addressing the challenges associated with its clinical development.

• 93866-13-8(4-(4-Methoxyphenoxy)quinazoline)
• 188569-30-4(6-Chloro-4-methoxyquinazoline)
• 17799-34-7(4-methoxy-9H-Pyrimido[4,5-b]indole)
• 16347-95-8(4-Methoxyquinazoline)
• 16347-97-0(4-phenoxyquinazoline)
• 155824-63-8(5-Quinazolinol,2,4-dimethoxy-)
• 101871-79-8(Quinazoline, 4-methoxy-2-methyl-)
• 88404-40-4(Quinazoline, 4,4'-oxybis-)
• 1341366-12-8(4-Methoxyquinazolin-6-amine)
• 6640-62-6(Quinazoline,2,4-diphenoxy-)